The original ASPIRE™ trial, which focused on evaluating the safety and efficacy of ExaStim® in a clinical setting, completed ...

The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...

Sacral neuromodulation, in which electrical pulses from an implanted device help control the bladder, was found to ease symptoms in MS.

As healthcare providers and patients increasingly recognize the benefits of neurostimulation therapies, the market is set for dynamic growth over the next decade. With the global burden of ...

?The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine, which combines ...

From sudden severe headaches to vision changes and neurological symptoms, discover the signs that indicate it's time to seek ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first ...

A new development in spinal cord injury treatment is offering new hope for those facing life-altering mobility challenges ...

Four weeks after LFBV, intervention group had significantly lower urinary leukocytes, postvoid residual volume, fewer signs and symptoms of UTI ...